France CPI: 06.1.1 medicines
France CPI: 06.1.1 medicines stood at 95.48 in Sep 2026, according to INSEE – Institut national de la statistique et des études économiques (BDM). It is one of the indicators in the Consumer price index table (Value · Monthly), with a complete series running from Jan 1996 to Sep 2026. The complete series with an interactive chart, free to download.
This indicator in the Consumer price index table
| Indicator | 09-2026 | 08-2026 | 07-2026 | 06-2026 | 05-2026 | 04-2026 | 03-2026 | 02-2026 | 01-2026 | 12-2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| By COICOP class | |||||||||||
| COICOP classification: 06.1.1 - Medicines (ND) | 95.48 | 95.5 | 95.81 | 95.96 | 96.13 | 96.41 | 97.1 | 98.27 | 98.78 | 98.84 | |
| COICOP classification: 06.1.2 - Medical products (ND) | 99.18 | 99.2 | 98.84 | 98.79 | 98.84 | 99.02 | 99.3 | 98.98 | 98.55 | 99.22 |
Understanding france CPI: 06.1.1 medicines
Pharmaceutical preparations and prescription remedies purchased at retail pharmacies by households form the foundation of this index component. The measurement encompasses both prescription drugs and over-the-counter medications that treat specific medical conditions, leaving out general wellness supplements or personal hygiene goods. Unlike medical equipment or therapeutic apparatuses, these items are consumed chemically during treatment regimens. The basket captures changes in out-of-pocket costs after public health reimbursements and complementary insurance schemes apply, reflecting the actual price burden faced by the consumer at the point of sale.
Analyzing price shifts requires attention to regulatory price controls, statutory reimbursement rate adjustments, and manufacturer discounting policies that can alter consumer-level expenditures independently of broader economic conditions. Seasonal patterns are generally muted, though pharmacy discounting cycles and modifications to national health insurance lists can introduce step changes. Year-on-year comparisons are preferred over month-on-month variations to smooth out the administrative timing of official drug tariff publications. Analysts should avoid equating shifts in this index with total national spending on health, as government subsidies often absorb a large share of actual medical costs before the transaction reaches the household budget.
Frequently asked questions
- What types of items are tracked under France CPI: 06.1.1 medicines?
- The index tracks prescription and over-the-counter pharmaceutical preparations acquired by households through retail pharmacy channels.
- How do public health reimbursements affect this series?
- The index measures out-of-pocket prices paid by consumers after mandatory statutory health insurance and complementary schemes are applied.
- Why use year-on-year comparisons for pharmaceutical price tracking?
- Annual comparisons help isolate price shifts from administrative updates to official drug tariffs and reimbursement list revisions.